Introduction
The health and survival of all organisms depends on proper differentiation and function of diverse cell types. During vertebrate development, a variety of distinct cell types are derived from a special precursor population called the neural crest (Le Douarin and Kalcheim, 1999; Knecht and Bronner-Fraser, 2002) . Neural crest cells originate dorsally at the top, or 'crest', of the neural tube in early development, and travel in well-defined migratory paths following epithelial-to-mesenchymal conversion and detachment from the neural tube (Erickson and Reedy, 1998) . Some follow a dorso-lateral pathway and differentiate to form melanocytes of the skin, hair, and inner ear while others move ventrally, either through the somites or in the space between the somites and the neural tube, and contribute to the formation of additional distinct lineage. These include sensory neurons and glia, neurons and glia of cranial ganglia, cartilage and bone, connective tissue, and neuroendocrine cells (Le Douarin and Kalcheim, 1999) .
The specification of neural crest to distinct lineage and their proper differentiation is dependent on both intrinsic factors and environmental interactions (LaBonne and Bronner-Fraser, 1998) . The use of mouse neural crest mutants has been instrumental in the identification and analysis of genes essential for proper neural crest function (Le Douarin and Kalcheim, 1999) . In particular, the critical role of a number of transcription factors in differentiation and function of neural crest cell (NCC) lineage was established using mouse mutants. This review article focuses on one such transcription factor called SOX10 (acronym for Sry-like HMG bOX), which has a significant function in proper development of the NCCs. We will present a synthesis of the current state of knowledge about SOX10 and its developmental role, discussing the implications of these findings and their relevance to future work.
Discovery of SOX10
Sox10 was first discovered by RT-PCR analysis of total RNA from 11.5-day-old mouse embryos (E11.5), using degenerate oligonucleotide primers directed against the high-mobility group (HMG) domain (Wright et al., 1993) . Members of the HMG-domain family are DNAbinding proteins that fall into a vast array of functional categories (Bianchi and Beltrame, 2000) . Their HMG designation relates to the observation that the family members initially analysed showed fast migration on SDS-PAGE. Sequence comparison showed that within the HMG group, SOX10 belongs to the SOX family of proteins, which are related to the mammalian testis determination factor SRY (Gubbay et al., 1990) . More than 20 vertebrate SOX members have been identified to date, and related genes have been found in Drosophila melanogaster and Caenorhabditis elegans (Wright et al., 1993; Pevny and Lovell-Badge, 1997; Wegner, 1999) . SOX proteins show restricted patterns of tissue-specific expression and are essential for a multitude of developmental processes, including nervous system development, bone morphogenesis, pigment cell formation, formation of the germ layer, development of the immune system, sex determination, and eye development (for reviews, refer to Pevny and Lovell-Badge, 1997; Wegner, 1999) . Based on pairwise comparisons of partial HMG-domain sequences, the SOX members were originally classified into six separate groups (A-E), with SOX8, SOX9, and SOX10 belonging to group E (Wright et al., 1993) . This was later expanded to seven (van de Wetering and Clevers, 1993; Meyer et al., 1996) and eight groups (A-H) (Osaki et al., 1999) , owing to the discovery of additional SOX genes. The latest refinements of these classifications are based on fulllength protein sequences comparisons. They consist of the addition of two new groups, I and J, in a study that included the invertebrate SOX sequences (Bowles et al., 2000) , and subdivision of group B into B1 and B2 (Uchikawa et al., 1999; Bowles et al., 2000; Kamachi et al., 2000) . Since its discovery in mouse, Sox10 homologues have been identified in several other vertebrates. In rat, the Sox10 gene was cloned from rat glial cells (Kulhbrodt et al., 1998a) . Human Sox10 was identified by characterization of a cosmid from a human chromosome-22-specific library and by comparative mapping studies (Pusch et al., 1998; SouthardSmith et al., 1999a) . Molecular analysis of the zebrafish mutation colourless (cls) led to the discovery of a Sox10 homologue in this organism (Dutton et al., 2001) . In chick, a Sox10 homologue was identified by screening of a chick embryo cDNA library with HMG-domainspecific degenerate primers (Cheng et al., 2000) . A Sox10-related homologue has also been identified in the invertebrate species D. melanogaster. The Drosophila homologue (Sox100B) was discovered by sequence homology within the HMG domain and is equally related to the Sox9 gene (Loh and Russell, 2000) . Its function in the fruit fly remains to be elucidated. A sequence comparison of SOX10 across these different species is presented in Figure 1 . This alignment shows the high degree of sequence conservation for SOX10 during evolution, underscoring its functional significance and suggesting that many of the mechanisms governing neural crest development may be conserved throughout vertebrate evolution.
Identification of Sox10 mutation in Waardenburg-Shah type IV mouse model
Interest in the functional role of SOX10 intensified with the discovery that the neurocristopathy phenotypes in the Dominant megacolon (Dom) mice are linked to a Sox10 mutation Southard-Smith et al., 1998) . The Dom mice arose spontaneously at the Jackson Laboratory and have served as a murine model for the Waardenburg-Shah syndrome type IV (WS-IV), a disorder that combines the features of the Waardenburg syndrome (Read, 2000) and Hirschsprung's disease (HSCR) (Shah et al., 1981; Badner and Chakravarti, 1990; Parisi and Kapur, 2000) . These include cochlear deafness and pigmentary defects (heterochromia iridis, white forelock and eyelashes, leukoderma) characteristic of the Waardenburg disorder, and enteric aganglionosis in the distal region of colon characteristic of the HSCR. The illustration of the genetic defect in the Dom mice led to the identification of Sox10 mutations in a number of individuals with WS-IV features Bondurand et al., 1999; Inoue et al., 1999; SouthardSmith et al., 1999b; Touraine et al., 2000; Sham et al., 2001a) . A Sox10 mutation (795delG) that does not give the established features of WS-IV but presents with phenotypes associated with abnormal neural crest development has also been identified in an individual . A list of these mutations, along with those identified in mice and zebrafish, is presented in Figure 2 . They include frameshift mutations, insertions, deletions, extensions, and point mutations, and span different domains of the SOX10 protein. However, no mutations within the regulatory region of Sox10 have been linked to neurocristopathy phenotypes to date. Identification of such mutations in the future should help with discovery of transactivating factors that modulate Sox10 expression.
SOX10 structure

HMG domain
A better appreciation of the functional properties of SOX10 requires an understanding of the structural mechanisms by which SOX10 binds its target DNA and regulates transcription. Similar to other HMG proteins, SOX10 binds its target DNA sequences via its HMG domain (Figure 2 ), and mutations in the HMG box disrupt SOX10 structure and compromise its binding to DNA (Southard-Smith et al., 1999b; Bondurand et al., 2000) . Model structures of the SOX10 HMG domain have been generated from human, rat, and mouse sequences by threading each sequence through the NMR coordinates of the second HMG-1 box from rat, followed by energy minimization studies to determine the most favorable conformation (Southard-Smith et al., 1999b) . The predicted structure is composed of three alpha-helices forming an L shape, which is proposed to facilitate binding to the DNA. The HMG box is highly conserved within the SOX family, with X90% amino-acid sequence identity within an individual SOX group and about 60% identity between distant groups (Kamachi et al., 2000) .
The evolutionary conserved HMG motif consists of about 80 amino acids and binds in the minor groove of DNA (Weiss, 2001) . In addition to conferring DNAbinding capacity, the L-shaped structure of HMG domain is known to allow DNA bending for several SOX proteins (Pevny and Lovell-Badge, 1997; Wegner, 1999) . In vitro studies with either the HMG domain of SOX10 alone, or with a truncated form that lacks sequences C-terminal to the HMG domain, have suggested that SOX10 also possesses DNA-bending properties . The degree of relevance of these observations to the in vivo chromatin environment within which SOX10 operates remains to be established. Nevertheless, experimental results for other SOX proteins suggest that this mode of DNA binding allows them to play an architectural role in forming transcriptionally active chromatin (Prior and Walter, 1996; Pevny and Lovell-Badge, 1997) .
Transcriptional activation domain
Similar to most SOX proteins analysed to date, SOX10 carries a classical transactivation domain (TA) at its Cterminus, rich in serine, proline, and glutamine residues ( Figure 2 , Pusch et al., 1998) . Deletion of this region in entirety abolishes the ability of SOX10 to induce promoter activity of its target genes in vitro Lee et al., 2000; Potterf et al., 2000; Verastegui et al., 2000; Potterf et al., 2001) . Furthermore, fusion of various segments of human SOX10 with the DNA-binding domain of yeast GAL4 shows that only the fusion construct carrying the TA domain is capable of CAT induction following cotransfection into cells with a GAL4-dependent CAT reporter plasmid (Pusch et al., 1998) . In vivo, several Sox10 mutations that lead to either a partial or full deletion of the TA domain have been identified (Figure 2 ). The Sox10 Dom mutation belongs to this group and entirely lacks the TA domain. Thus, a translational frameshift downstream of the HMG box removes the TA domain and adds 99 extraneous residues ( Figure 2 ; Herbarth et al., 1998; Southard-Smith et al., 1998) . In vivo studies have shown that the ability of SOX10 to induce its target genes is considerably compromised in Sox10 Dom heterozygous mice (Potterf et al., 2000 (Potterf et al., , 2001 . The TA function may also be compromised without removal of any TA domain residues. In an individual with WS-IV and with associated myelin deficiencies, a Sox10 mutation was identified in which the TA domain is extended by 82 amino acids without any disruption of the coding region (Inoue et al., 1999) . It is postulated that the TA domain activity in this mutation is compromised through interference from a proline-rich region that occurs within the extension and has homology to Wilms' tumor (WT1) proline-rich represser motif. These studies together demonstrate the ability of the TA domain of SOX10 to activate transcription. However, it should be noted that they do not formally exclude the possibility that SOX10 may serve as a repressor in certain cellular contexts.
SOX10 binding sites and monomeric versus heteromeric mode of binding
Characterization of SOX10 binding sequences facilitates the identification of those genes that are directly targeted by SOX10 and further elucidates the mechanisms by which SOX10 mediates gene activation. In vitro studies using a collection of random sequences identified Figure 2 Schematic representation of the SOX10 protein and location of all Sox10 mutations identified to date. The 'X' symbol is placed next to the mouse mutation 929insG Dom (green), and the zebrafish mutation N85ins (red), to indicate that these frameshift mutations cause the introduction of heterologous amino acids before terminating the protein prematurely. The SOX10 diagram is drawn to scale, with the corresponding amino-acid numbers marked below the figure in 50-residue blocks SOX10 function in neural crest development R Mollaaghababa and WJ Pavan 5 0 -AACAAT-3 0 as the core binding sequence for the HMG domains of SRY, SOX5, SOX9, and SOX17, with subtle differences in the flanking nucleotides (Denny et al., 1992; Harley et al., 1994; Kanai et al., 1996; Mertin et al., 1999) . A degree of degeneracy exists within this core sequence as both adenosine and thymidine are allowed at three of the positions (5 0 -A/ TA/TCAAT/A-3 0 ). Using this core sequence as reference, SOX10 binding sites have been identified within promoter regions of several SOX10 target genes (Table 1) . A considerable degree of sequence variability exists among these sites, suggesting that other determinants such as flanking sequences, protein-protein interactions, or cooperative interactions with other bound factors may improve specificity of SOX10 binding within the cell.
Indeed, an analysis of the promoter region for the protein zero (P0) gene, a myelin glycoprotein that is targeted by SOX10, has shown that flanking sequences and cooperative binding of SOX10 dimers to adjacent target sites are important determinants of binding specificity for SOX10 . Analysis of the proximal region of the P0 gene promoter has identified two types of DNA response elements . One allows binding of SOX10 in monomeric form (designated site B), whereas the second type promotes cooperative binding of two SOX10 molecules as a dimer (designated site C), with dimer formation improving binding specificity. Site C is actually composed of two adjacent binding sites that are separated by only four base pairs and are oriented toward one another (C and C 0 ). The spacing between these binding sites and their orientations are important determinants of dimer formation and binding strength. In addition, the sequences flanking the sites greatly influence SOX10 binding. The dimer formation also improves the DNAbending ability of SOX10 in vitro . It is of note that a similar arrangement of adjacent SOX10 binding sites, separated by only a few base pairs, can be found in the promoter regions of other direct targets of SOX10, either in the glial or in the melanocyte lineage (Table 1 ). The recurrence of adjacent SOX10 binding sites in promoters of targets other than P0 provides a rationale for future analysis of these sites to see if the dimeric mode of binding by SOX10 is used as a general mechanism for improving binding specificity and DNA bending.
Sox10 mutant phenotypes
The crucial role of SOX10 in the proper development of NCCs is manifested by severe neurocristopathy phenotypes that are observed in humans, mice, and fish with either a complete lack of SOX10 function or a significant reduction in SOX10 activity (Figure 2 ). The occurrence of the phenotypes observed in Sox10 Dom /+ heterozygous mice and in Sox10 Dom
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Dom homozygous embryos is consistent with the observed expression patterns of Sox10 in human and mouse. They encompass expression in emerging NCCs and neural crest derivatives (Figure 3 ; Bondurand et al., 1998; Herbarth et al., 1998; Kuhlbrodt et al., 1998a; Pusch et al., 1998; Southard-Smith et al., 1998; Kapur, 1999) , including the enteric ganglia of HSCR patients (Sham et al., 2001b) and mouse embryos (Figure 3) , and expression in the and Site inner ear during mouse development (Watanabe et al., 2000) . The Sox10 Dom heterozygous mice show enteric aganglionosis (megacolon) and hypopigmentation phenotypes characteristic of WS-IV. Similar to individuals with HSCR, the hypopigmentation and megacolon phenotypes show variable penetrance and expressivity in these mice, and the severity of the phenotypes is modulated by the genetic background on which the mice are kept (Lane and Liu, 1984; Kapur et al., 1996; Southard-Smith et al., 1999a) . The homozygous Sox10 Dom mice die during gestation, and the primary reason for the observed embryonic lethality is not established. Recently, impaired function of the autonomous nervous system of the heart was detected in an individual with WS-IV who carried a truncated form of SOX10 (Korsch et al., 2001) . This observation suggests the possibility that embryonic lethality in homozygous Sox10 Dom embryos may be a result of abnormal autonomic regulation of the heart. The homozygous Sox10 Dom embryos are either missing or severely deficient for several neural crest derivatives such as dorsal root ganglia (DRG), several cranial ganglia, and sympathetic and enteric ganglia (Southard-Smith et al., 1998; Kapur, 1999) .
More recently, knockin mice in which the Sox10 coding region is replaced by the LacZ gene have been engineered, and they exhibit similar deficiencies as the Sox10 Dom mice (Britsch et al., 2001) . While the Sox10 lacz knockin is a loss-of-function mutation, the Sox10 Dom mutation may act as a dominant-negative allele. This prediction is based on the observation that the TAdeleted forms of Sox10 show dominant negative properties in vitro (Potterf et al., 2000; 2001) , suggesting that the Sox10 Dom mutant protein may act in a similar manner. However, a careful comparison of the Sox10 Dom and null alleles for penetrance and expressivity of the Sox10 phenotypes needs to be performed using similar genetic backgrounds. In the next section, we discuss the current findings in regard to the cellular basis of the Sox10 mutant phenotypes.
Role of SOX10 in neural crest development NCC formation appears normal in the absence of SOX10 function. Neural crest-derived embryonic structures are present in Sox10
Dom
/Sox10
Dom or Sox LacZ / Sox10
LacZ homozygous embryos Southard-Smith et al., 1998; Britsch et al., 2001) , and P75+ (NCC marker) cells can be isolated from the DRG of Sox10À/À embryos at E13 (Paratore et al., 2001) . Therefore, Sox10 is not required for initial neural crest specification. The appearance of NC-derived embryonic structures in Sox10À/À embryos indicates that the initial migration of at least some of the specified NCCs is also undisturbed in the absence of SOX10. This suggests that SOX10 is not required for NCC migration either, at least in the earlier stages. However, the multipotent postmigratory NCCs that form and migrate in the absence of SOX10 undergo apoptosis before reaching maturation stage. TUNEL analysis of Sox10-
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LacZ homozygous embryos at XE9 shows significant increase in cell death compared to their age-matched wild-type littermates (Southard-Smith et al., 1998; Kapur, 1999; Paratore Figure 3 Expression of SOX10 protein in the neural crest-derived structures of mouse embryos. A purified anti-SOX10 antibody, directed against a stretch of amino-acid residues unique to SOX10, was used for staining of endogenous SOX10 (brown) in sections of E13.5 mouse embryos (R Mollaaghababa and William J Pavan, unpublished). To improve contrast, the sections were counter stained with hematoxylin. SOX10 expression is clearly observed in the DRG, the ventral spinal nerves, the vagus nerve, the esophagus (enteric nervous system), and in dermis. Arrowheads show the location of SOX10+ cells within the neural tube (NT), presumably corresponding to oligodendrocyte precursors. 
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Dom homozygous embryos by E11.5 (Britsch et al., 2001) . Sensory and motoneurons form in these homozygous mutants but subsequently degenerate, presumably because of the absence of a surrounding glial cell population as SOX10 expression is not observed in marked neurons. Recent results show that P53 is involved in the mediation of apoptosis in mouse embryos that lack the paired homeodomain transcription factor Pax3 (Pani et al., 2002) . Since PAX3 shows synergistic interaction with SOX10 in certain cellular contexts Lang et al., 2000; Potterf et al., 2000) , the programmed cell death in Sox10-deficient cells may also involve the P53 pathway. Based on Brdu analysis, it has been suggested that SOX10 is also important for cell proliferation in DRG between E9 and E11, with the most significant effect observed at E10 (Sonnenberg- . However, the interpretation of these results is complicated by the fact that at E10 a significant number of DRG cells are undergoing apoptosis in Sox10-deficient embryos (Sonnenberg- , raising the possibility that the observed effect on proliferation is an indirect consequence of programmed cell death.
Is the absence of specific NC derivatives within the PNS of Sox10-deficient embryos an indirect consequence of the death of undifferentiated NCCs? Or, is SOX10 also crucial in promoting the differentiation of such lineage in addition to regulating cell survival? Under culture conditions in which the fate of individual NCCs can be followed, the surviving Sox10À/À NCCs fail to produce any glia in a differentiation medium that promotes gliogenesis in wild-type progenitors of NCCs (Paratore et al., 2001) . Instead, they give rise to P75-(NCC marker) and NF160-(neuronal marker) cells that show non-neural morphology and often express the smooth muscle cell marker actin (SMA). Under similar differentiation conditions, cultured haploinsufficient Sox10+/À NCC clones also show altered fate determination compared to wild-type NCCs, without showing any difference in survivability (Paratore et al., 2001) . In these haploinsufficient cultures prepared at clonal density, gliogenesis remains drastically reduced even in the presence of neuregulin-1 (NRG1), a ligand for the tyrosine kinase receptor ErbB3, which significantly increases glial fate acquisition in wild-type NCC cultures (Shah et al., 1994; Shah and Anderson, 1997; Adlkofer and Lai, 2000) . These observations demonstrate the importance of SOX10 in glial fate determination within the PNS in addition to its role in promoting the survival of undifferentiated NCC precursors. The instructive capacity of SOX10 for glial formation appears to be in part dependent on cell-cell interactions as, in contrast to clonal cultures, haploinsufficient Sox10+/À NCCs that are plated at high density are capable of generating significant numbers of glial cells upon NGR1 addition (Paratore et al., 2001) . This cell-cell signaling effect might either be mediated via a pathway that involves SOX10 or might be part of an independent pathway for gliogenesis. The ability of SOX10 to influence melanocyte differentiation is also documented. As it will be further discussed in the next section, SOX10 directly regulates the expression of the Microphthalmia (Mitf) transcription factor, which plays a critical role in promoting melanocyte differentiation (for a review, see Goding, 2000) . Therefore, SOX10 function appears to be critical for both the survival of NCC progenitors and the proper differentiation of NC-derived glia and melanocytes. Future studies with Sox10 transgenic mice will provide a powerful tool for examining the lineage determination role of SOX10 in vivo.
Sox10 is also expressed in mouse oligodendrocyte progenitors within both the spinal cord and the brain (Stolt et al., 2002; Figure 3) , with expression in these regions continuing into adulthood (Kuhlbrodt et al., 1998a; Southard-Smith et al., 1999b) . The spinal cord oligodendrocyte precursors are specified ventrally at E11.5 within the ventricular zone. As they commence their terminal differentiation several days later, they express a number of different myelin proteins such as myelin-associated glycoprotein (MAG), proteolipid protein (PLP), and myelin basic protein (MBP), and show significant increase in numbers until birth. Unlike the Schwann cell progenitors within the PNS, these precursors survive in the absence of SOX10 function. However, they fail to differentiate into myelinating oligodendrocytes later in development, as indicated by lack of MAG, PLP, and MBP expressions (Stolt et al., 2002) . These observations are consistent with the occurrence of PNS and CNS myelin deficiencies in an individual with WS-IV who carries a presumed dominant-negative Sox10 mutation (Inoue et al., 1999) , and the occurrence of neurological features attributable to myelin deficiency of CNS and PNS in several other WS-IV individuals Southard-Smith, et al., 1999b; Touraine et al., 2000) . The differential importance of Sox10 only for survival of glial precursors in the PNS and not the CNS may be because of functional redundancies from other SOX proteins that are present in oligodendrocyte progenitors. While SOX10 appears to be significantly more abundant than other SOX proteins in Schawnn cells, in oligodendrocyte precursors SOX4 and SOX11 are also robustly expressed prior to their downregulation at the time of differentiation (Kuhlbrodt et al., 1998b) . Therefore, the survival of Sox10-deficient oligodendrocyte precursors may be a result of compensatory functions from SOX4 and/or SOX11 proteins.
SOX10 targets and synergistic interactions of SOX10 with other transcription factors
What are the genes that are regulated by SOX10 to promote glial and melanocyte differentiation and what other factors are involved in activation of these genes? SOX10 function in neural crest development R Mollaaghababa and WJ Pavan
Although these questions have not yet been fully answered and continue to motivate research in this area, a number of direct targets of SOX10 and transcription factors that show synergism with SOX10 have been identified (Table 1 ). In the melanocyte lineage, SOX10 directly regulates the expression of the Mitf gene Lee et al., 2000; Potterf et al., 2000; Verastegui et al., 2000) , a bHLH-LZ transcription factor that promotes differentiation of NC-derived melanocytes (Hodgkinson et al., 1993) . Initially, it was observed that Sox10 Dom / +; Mitf mi /+ double heterozygous mice show considerable increase in loss of pigmentation compared to heterozygous mice that carry only one of the two mutations (Potterf et al., 2000) , prompting further investigation of the link between these two transcription factors. Transient transfection assays showed that SOX10 acts as a potent activator of the melanocytespecific promoter of the Mitf gene (M promoter) Lee et al., 2000; Potterf et al., 2000; Verastegui et al., 2000) . Evidence suggests that this transactivation is direct as electrophoretic mobility shift assays (EMSA) have demonstrated that SOX10 binds two of the identified target sites within this promoter region with high affinity Lee et al., 2000; Potterf et al., 2000; Verastegui et al., 2000) . More recent results suggest the existence of an additional group of putative SOX10 binding sites in a more distal regulatory region of the M promoter (Watanabe et al., 2002) . Consistent with these observations in mice, expression of the zebrafish Mitf homologue, nacre, is absent in NCCs of colourless mutants (Dutton et al., 2001) .
Two independent studies of Mitf activation by SOX10 in HELA cells reported synergistic interaction of SOX10 with PAX3 to activate Mitf expression, consistent with the presence of a PAX3 binding site in the Mitf promoter Potterf et al., 2000) . This synergy is also observed in NIH3T3 cells . However, studies of Mitf activation by SOX10 in melanoma cell lines did not provide evidence for any SOX10-PAX3 synergy (Lee et al., 2000; Verastegui et al., 2000) . Aside from variables such as transfection efficiencies and protein levels, these apparently contradictory results may simply reflect somewhat distinct mechanisms of action for SOX10 and PAX3 in different cellular contexts (HELA and NIH3T3 versus melanoma cell lines). In this regard, it is noteworthy that SOX10-PAX3 synergism has also been reported in activation studies of the c-ret gene using NIH3T3 and 293T cells (Lang et al., 2000) . Since the PAX3 binding site within the Mitf promoter is adjacent to the identified SOX10 binding sites, one might speculate that the observed synergism between SOX10 and PAX3 involves direct protein-protein interactions. However, no evidence supporting this model has been presented to date, and it is possible that the SOX10-PAX3 synergy instead involves a reconfiguration of the DNA at and around their adjacent binding sites to allow an increased rate of transcription.
SOX10 also regulates the expression of the Dopachrome tautomerase gene (Dct), which functions in melanin biosynthesis (Britsch et al., 2001; Potterf et al., 2001) . In Sox10 Dom /+ heterozygous embryos at E11.5, Dct expression is severely reduced in the trunk and cranial regions (Potterf et al., 2001) , and similar results are obtained from comparison of Sox10 LacZ /+ and wildtype embryos at E12.5 (Britsch et al., 2001) . Consistent with these in vivo results, DCT+ cells are absent in agematched neural tube explants obtained from Sox10 Dom / +; Dct promoter-LacZ embryos and double stained for the SOX10 protein and the DCT transgene (Potterf et al., 2001) . Intriguingly, Dct expression is significantly restored later in development. Sox10 Dom /+ heterozygous embryos show a partial but significant restoration of Dct expression by E14.5, and DCT+ cells are observed in neural tube explants obtained from these embryos and matched in age to E14.5 (Potterf et al., 2001) . This suggests that SOX10 regulation of Dct expression may be transient, with separate regulatory elements fulfilling any need for Dct activation later in development. Alternatively, it is possible that a gradual accumulation of the wild-type SOX10 protein partially overcomes the effect of the Sox10 Dom allele, allowing significant restoration of Dct expression with the passage of time. Further analysis of the Dct promoter region is needed to determine whether SOX10 directly transactivates the Dct gene.
Several direct targets of SOX10 have also been identified in the nervous system. SOX10 transactivation of the neuronal nicotinic acetylcholine receptor b4 and a3 subunit genes in vitro has been reported, with direct interaction of SOX10 with the b4 gene promoter (Liu et al., 1999) . The b4, a3, and a5 subunits are the predominant receptor subtypes within the PNS (Conroy et al., 1993; Conroy and Berg, 1995) . Based on in vitro protein binding assays, it has been postulated that SOX10 activation of the b4 gene involves direct interactions between SOX10 and SP1, SP3, Pura, and hnRNPK, all of which are binding factors that affect b4 gene regulation (Melnikova et al., 2000a, b) . To test this hypothesis further, pull-down assays of whole-cell extracts need to be performed, using a specific anti-SOX10 antibody to demonstrate the presence of SOX10 in the putative complex. Also, in vivo regulation of b4 and a3 genes by SOX10 needs to be tested.
The SOX10 protein also directly regulates the c-ret tyrosine receptor kinase gene, which plays an important role in the proper development of the enteric nervous system (Lang et al., 2000) . Interestingly, as with regulation of Mitf, SOX10 shows synergistic interaction with PAX3 to activate c-ret expression. Also, similar to the Mitf promoter, the identified PAX3 and SOX10 binding sites within the c-ret promoter are in close proximity (Lang et al., 2000) . Mutations in c-ret and its ligand, glial cell-derived neurotrophic factor (Gdnf), and in endothelin receptor B (Ednrb) and its ligand endothelin 3 (Edn3), have also been linked to longsegment HSCR (Gabriel et al., 2002) . Activation of c-ret by SOX10 suggests that the same pathway may be affected in HSCR mutations of these genes. Given the overlapping expression patterns of Ednrb and Sox10 in embryos (Southard-Smith et al., 1998) and similarity of their mouse mutant phenotypes (hypopigmentation and megacolon) (Hosoda et al., 1994; Pavan and Tilghman, 1994) , SOX10 and EDNRB might also function as parts of the same pathway.
In glia, the mouse P0 gene and human connexin 32 (Cx32) genes have been shown to be direct targets of SOX10 Bondurand et al., 2001) . The P0 gene product is a highly abundant structural protein of the peripheral myelin sheath (Suter and Snipes, 1995) , and Cx32 is a gap junction protein associated with myelin in the PNS and CNS (Scherer et al., 1995) . The direct regulation of these genes by SOX10 shows that, in addition to being important for CNS myelination, SOX10 also has a critical role for myelination within the PNS. Similar to the P0 promoter, two adjacent SOX10 binding sites were found within the promoter of Cx32 gene, and in addition, target sites for the transcription factor EGR2 (human homologue of Krox20) were identified in the vicinity (Bondurand et al., 2001) . Transfection assays show synergistic interaction between EGR2 and SOX10 in activating Cx32 gene, although as with SOX10-PAX3 synergism, the mechanism of this cooperative interaction remains to be elucidated. In the PNS, expression of the erbB3 gene is also influenced by SOX10 (Britsch et al., 2001) , although the presence of SOX10 binding sites within erbb3 gene promoter has not been reported and therefore it is not clear whether SOX10 regulation of this gene is direct. ErbB3 is an EGF receptor tyrosine kinase that binds neuregulins and, similar to SOX10, has a critical function in the development of neural crest derivatives including Schwann cells (Riethmacher et al., 1997; Britsch et al., 2001) . The upregulation of erbB3 by SOX10 was demonstrated in vivo by comparing wildtype and Sox10
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Dom embryos at E9.0 and E10.5, and in vitro by RT-PCR analysis (Britsch et al., 2001) . While erbB3 regulation is affected by SOX10 function in the PNS glia, control of erbB3 expression in the CNS oligodendrocytes does not require SOX10 function (Stolt et al., 2002) . This suggests that the effects of SOX10 in peripheral and central glia are mediated through distinct mechanisms. This specificity may be determined by a combinatorial function of SOX10 and other transcription factors with which it shows synergistic interaction. Besides PAX3 and ERG2, this list may include the glial POU-domain protein Tst-1/Oct6/ SCIP with which SOX10 shows synergistic interaction on artificial promoters (Kuhlbrodt et al., 1998a, c; Bondurand et al., 1999) , and additional transcription factors may also be involved.
Future directions
Despite the continuous accumulation of knowledge about SOX10 over the last few years, several lines of investigation merit pursuit. While the phenotypes associated with loss of Sox10 function have been characterized, Sox10 gain-of-function phenotypes have not been reported. Such phenotypes can be studied by construction of Sox10 transgenic mice, addressing the question of whether SOX10 can function as a lineage determination factor in vivo. Sox10 conditional knockout mice also need to be engineered and will provide a powerful tool to study SOX10 function in later embryogenesis and during the postnatal period. Another area for further exploration is the discovery of additional genes that are regulated by SOX10. Although several PNS targets of SOX10 have been determined, the genes that are regulated by SOX10 in the CNS remain to be identified and other targets may also exist in the melanocyte and PNS lineage. Furthermore, little is known about the transactivating factors that regulate expression of Sox10 itself. A full characterization of the Sox10 promoter region and other upstream regulatory elements will help with their identification. One current candidate is the bHLH transcription factor Olig2, since it is expressed prior to SOX10 in oligodendrocyte progenitors and plays an essential role in oligodendrocyte differentiation Zhou et al., 2000; Lu et al., 2002; Zhou and Anderson, 2002) . The possible connection between SOX10 and the Olig genes needs to be investigated and any additional upstream regulators need to be identified. Microarray analysis of cell-typespecific libraries, such as the one characterized for the melanocyte lineage (Loftus et al., 1999) , can serve as a powerful tool in the discovery of genes that act either upstream or downstream of Sox10 in particular cell types. In addition, the use of genetic modifier screens in vivo and the NCC culture and the neural tube explant culture systems in vitro (Stemple and Anderson, 1992; Dunn et al., 2000) should also prove invaluable tools in these endeavors. Current data strongly suggest that, as anticipated, SOX10 does not function in isolation and has synergistic interactions with several other transcription factors. Elucidation of the underlying mechanisms of these synergistic interactions, including identification of the factors that may directly bind to SOX10, will greatly enrich our understanding of how SOX10 regulates transcription. Biochemical approaches will be indispensable tools for addressing these questions in the future. In short, we anticipate that the area of research on SOX10 function and the mechanisms of neural crest development in general will remain very active and vibrant in the foreseeable future.
